CHARLES H SHERWOOD Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES H SHERWOOD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES H SHERWOOD. CHARLES H SHERWOOD is President and CEO in Anika Therapeutics, Inc. ($ANIK).
Latest Insider Trading Transactions of CHARLES H SHERWOOD
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | M | 8.71 | 50,000 | 435,500 | 0 | |
Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 32.02 | 16,600 | 531,532 | 16,600 | |
Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 39.69 | 34,200 | 1,357,398 | 34,200 | |
Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Grant | A | 8.71 | 50,000 | 435,500 | 241,455 | 191.5 K to 241.5 K (+26.12 %) |
Feb 05 2015 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Grant | A | 0.00 | 13,500 | 0 | 191,455 | 178 K to 191.5 K (+7.59 %) |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 6.36 | 100,000 | 636,000 | 0 | |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 3.05 | 82,000 | 250,100 | 0 | |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 10.99 | 57,530 | 632,255 | 0 | |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 12.36 | 49,000 | 605,640 | 0 | |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 10.51 | 49,000 | 514,990 | 0 | |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Payment of Exercise | F | 47.46 | 189,381 | 8,988,022 | 177,955 | 367.3 K to 178 K (-51.56 %) |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 6.36 | 100,000 | 636,000 | 367,336 | 267.3 K to 367.3 K (+37.41 %) |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 3.05 | 82,000 | 250,100 | 267,336 | 185.3 K to 267.3 K (+44.24 %) |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 10.99 | 57,530 | 632,255 | 185,336 | 127.8 K to 185.3 K (+45.01 %) |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 12.36 | 49,000 | 605,640 | 127,806 | 78.8 K to 127.8 K (+62.18 %) |
May 07 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 10.51 | 49,000 | 514,990 | 78,806 | 29.8 K to 78.8 K (+164.40 %) |
May 02 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 44.32 | 83,780 | 3,713,130 | 29,806 | 113.6 K to 29.8 K (-73.76 %) |
Mar 03 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 41.09 | 150,000 | 6,163,500 | 113,586 | 263.6 K to 113.6 K (-56.91 %) |
Mar 03 2014 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Sell | S | 43.53 | 50,000 | 2,176,500 | 263,586 | 313.6 K to 263.6 K (-15.94 %) |
Dec 10 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.05 | 22,873 | 24,017 | 358,780 | 335.9 K to 358.8 K (+6.81 %) |
Dec 10 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.05 | 17,127 | 17,983 | 335,907 | 318.8 K to 335.9 K (+5.37 %) |
Mar 16 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Payment of Exercise | F | 12.15 | 20,000 | 243,000 | 318,780 | 338.8 K to 318.8 K (-5.90 %) |
Mar 16 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.16 | 37,500 | 43,500 | 338,780 | 301.3 K to 338.8 K (+12.45 %) |
Mar 16 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.05 | 12,500 | 13,125 | 301,280 | 288.8 K to 301.3 K (+4.33 %) |
Mar 08 2012 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 6.99 | 75,000 | 524,250 | 75,000 | |
Jun 13 2011 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Buy | M | 1.17 | 102,500 | 119,925 | 288,780 | 186.3 K to 288.8 K (+55.02 %) |
Jan 20 2011 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 6.98 | 95,000 | 663,100 | 95,000 | |
Jan 28 2010 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 6.36 | 100,000 | 636,000 | 100,000 |
Page: 1